Celladon Corp (CLDN)

19.77
0.50 2.59
NASDAQ : Health Care
Prev Close 19.27
Open 19.13
Day Low/High 19.00 / 19.89
52 Wk Low/High 12.90 / 28.35
Volume 22.76K
Avg Volume 10.50K
Exchange NASDAQ
Shares Outstanding 1.59M
Market Cap 27.50M
EPS -27.30
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Celladon (CLDN) Stock Popping on Eiger Merger

Celladon (CLDN) Stock Popping on Eiger Merger

Celladon (CLDN) stock is soaring on heavy trading volume on Thursday, after the company announced a merger with the privately-held Eiger BioPharmaceuticals.

CELLADON ALERT: Shareholder Rights Law Firm Johnson & Weaver, LLP Launches An Investigation Into The Proposed Merger Of Celladon Corporation; Are Celladon Shareholders Getting A Fair Deal?

CELLADON ALERT: Shareholder Rights Law Firm Johnson & Weaver, LLP Launches An Investigation Into The Proposed Merger Of Celladon Corporation; Are Celladon Shareholders Getting A Fair Deal?

Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of Celladon Corporation (NASDAQ: CLDN) breached their fiduciary duties in connection with the proposed...

Spark Tries to Quell Investor Fears About Gene Therapy Test

Spark Tries to Quell Investor Fears About Gene Therapy Test

Spark Therapeutics provided details Thursday about changes made to a clinical trial involving the company's gene therapy, trying to calm jittery biotech investors before study results next month.

5 Stocks With Ominous Insider Selling as Market Took Painful Turn

5 Stocks With Ominous Insider Selling as Market Took Painful Turn

Beware of companies where 'insiders,' often top executives, are selling large blocks of stock. Here are five to closely monitor.

GPM Announces The Filing Of A Securities Class Action On Behalf Of Celladon Corp. Investors

GPM Announces The Filing Of A Securities Class Action On Behalf Of Celladon Corp. Investors

Glancy Prongay & Murray LLP ("GPM") announces the filing of a class action lawsuit on behalf of investors of Celladon Corporation ("Celladon" or the "Company") (NASDAQ:CLDN), who purchased shares between July 7,...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Celladon Corporation Of Pendency Of Class Action Lawsuit And A Lead Plaintiff Deadline Of August 31, 2015

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Celladon Corporation Of Pendency Of Class Action Lawsuit And A Lead Plaintiff Deadline Of August 31, 2015

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Celladon Corporation ("Celladon") (NASDAQGM:CLDN) between July...

TRADING ALERT: The Rosen Law Firm Reminds Celladon Corporation Investors Of The Important Deadline In The Class Action - CLDN

TRADING ALERT: The Rosen Law Firm Reminds Celladon Corporation Investors Of The Important Deadline In The Class Action - CLDN

The Rosen Law Firm, a global investor rights firm, reminds purchasers of Celladon Corporation (NASDAQ: CLDN) common stock from July 7, 2014 through June 25, 2015, all dates inclusive, of the important August 31, 2015 lead...

SECURITIES FRAUD ALERT: The Law Firm Of Andrews & Springer LLC Announces That A Securities Fraud Class Action Has Been Filed Against Celladon Corporation - CLDN

SECURITIES FRAUD ALERT: The Law Firm Of Andrews & Springer LLC Announces That A Securities Fraud Class Action Has Been Filed Against Celladon Corporation - CLDN

Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, announced today that a securities fraud class action lawsuit has been filed in the U.

EQUITY ALERT: The Rosen Law Firm Announces The Filing Of A Securities Class Action Lawsuit Against Celladon Corporation

EQUITY ALERT: The Rosen Law Firm Announces The Filing Of A Securities Class Action Lawsuit Against Celladon Corporation

The Rosen Law Firm, a global investor rights firm, announces that a class action lawsuit has been filed on behalf of purchasers of Celladon Corporation (NASDAQ:CLDN) common stock from July 7, 2014 through June 25, 2015, all...

10 Worst Biotech Stocks in the NASDAQ

10 Worst Biotech Stocks in the NASDAQ

Some biotech stocks way underperformed in this red-hot sector.

Celladon (CLDN) Stock Tanks on Possible Liquidation

Celladon (CLDN) Stock Tanks on Possible Liquidation

Celladon (CLDN) shares are falling more than 40% after the company announced that it's halting R&D as it prepares for a possible liquidation.

Biotech Stock Mailbag: Unstoppable Heron, Aerie Disclosure Fail, Gene Therapy, Hate Mail!

Biotech Stock Mailbag: Unstoppable Heron, Aerie Disclosure Fail, Gene Therapy, Hate Mail!

Biotech columnist Adam Feuerstein answers readers' questions about health care.

4 Breakout Biotech Stocks Under $10 to Watch

4 Breakout Biotech Stocks Under $10 to Watch

These biotech stocks that trade for under $10 a share could be setting up to break out and trade higher soon.

Avalanche Fails Common-Sense Test, Kicked Out of Gene Therapy Credibility Club

Avalanche Fails Common-Sense Test, Kicked Out of Gene Therapy Credibility Club

I wanted to slam my forehead against the desk after the Avalanche CEO repeated for the 600th time, 'The key takeaway today is that it's a positive study.'

3 Stocks Under $10 Triggering Breakout Trades

3 Stocks Under $10 Triggering Breakout Trades

These under-$10 are making big moves higher today. Keep them on your breakout trading radar.

Celladon (CLDN) Stock Rises After Announcing Strategic Acquisition Plan

Celladon (CLDN) Stock Rises After Announcing Strategic Acquisition Plan

Celladon (CLDN) shares are gaining after the company announced that it is seeking an acquisition partner and hired Wedbush to facilitate the deal.